July 27 (Reuters) - Zenitas Healthcare Ltd ZNT.AX
* Announces that it has acquired 100% of dimple group
* Zenitas reaffirms prospectus pro forma forecast ebitda of $6.6m for Fy17. Post transaction, pro forma FY17 ebitda would increase to $11.8m
* Transaction funded via $10.7 mln of cash and bank debt and $2.7 mln of zenitas scrip
* Deal highly accretive to zenitas eps, with pro forma fy17 eps accretion of 22% after non- controlling interests and pre-synergy benefit